Radiation timing for spreading esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial compares giving radiation all at once versus in two stages for people with esophageal cancer that has spread to a few other spots. The goal is to see which approach controls the cancer better with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a confirmed diagnosis of esophageal squamous cell carcinoma.
- Your cancer has spread to 5 or fewer distant spots (like other organs or lymph nodes), and each spot is 5 cm or smaller.
- You have not had chemotherapy, radiation, or surgery for any cancer in the past 6 months.
- Your overall health is good enough to carry out daily activities (ECOG 0-1) and you have not lost more than 10% of your weight in the last 6 months.
- You are willing to use contraception during the study and for 6 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of targeted radiation (SBRT) and immunotherapy for people with esophageal cancer that has spread to a few spots in the body. The goal is to see if this approach helps control the cancer and improves your well-being.
This trial studies how to best target radiation for people with advanced esophageal cancer who are also getting immunotherapy. It aims to improve treatment planning to help patients live longer with fewer side effects.
This trial tests a short course of radiation combined with two drugs (raltitrexed and tislelizumab) for people with esophageal cancer that has returned after standard treatment. The goal is to see if these combinations can shrink tumors and improve survival.
This trial tests whether adding radiation therapy to a standard treatment (immunotherapy plus chemotherapy) can help people with advanced esophageal cancer that has spread to up to two organs. The goal is to see if the combination improves outcomes.
This trial tests whether adding radiotherapy can help people with metastatic esophageal cancer that has already responded well to initial treatment with immunotherapy and chemotherapy. It may offer a way to improve outcomes for those whose cancer has not progressed after 2-4 cycles of first-line treatment.
This trial tests whether giving local treatments (like surgery or radiation) to cancer spots later—after starting immunotherapy or targeted therapy—helps people with stomach or esophageal cancer that has spread to a few places. It aims to improve outcomes by timing treatments carefully.
Hear when a new Advanced Esophageal Squamous Carcinoma With Oligometastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.